Abiopharma

HCA Healthcare - HCA Healthcare Surpasses 100,000 Pounds of Collected Medication in Year Seven of Annual“Crush the Crisis”

Gilead - Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial

Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study